On Nov 13, major Wall Street analysts update their ratings for $Aramark (ARMK.US)$, with price targets ranging from $40 to $46.
Morgan Stanley analyst Toni Kaplan maintains with a hold rating, and adjusts the target price from $38 to $40.
J.P. Morgan analyst Andrew Steinerman maintains with a buy rating, and adjusts the target price from $41 to $45.
UBS analyst Joshua Chan maintains with a buy rating, and adjusts the target price from $44 to $46.
Jefferies analyst Stephanie Moore maintains with a buy rating, and maintains the target price at $45.
Stifel analyst Shlomo Rosenbaum maintains with a buy rating, and adjusts the target price from $43 to $45.
Furthermore, according to the comprehensive report, the opinions of $Aramark (ARMK.US)$'s main analysts recently are as follows:
The firm has adjusted its future adjusted AOI estimates upwards by 1.5% for FY25 and 3% for FY26 in response to Aramark's reported Q4 organic growth, which was modest. The company's reported AOI and EPS were roughly in line with projections, and their outlook for FY25 met expectations.
Aramark's recent quarter was described as having a mixed performance. The company experienced some notable contract terminations and intentionally stepped away from contracts with lower margins, along with a few significant deals being postponed to the next quarter, leading to revenues for the fourth quarter and forward-looking guidance that didn't meet expectations. Nevertheless, these incidents are regarded as occasional, rather than indicative of a shift in the company's overall direction. The company's narrative remains favorable in the eyes of the analyst.
The firm stated that Q4 results aligned with expectations across the business, noting that organic revenue growth slowed as anticipated alongside solid and predicted AOI margins.
Here are the latest investment ratings and price targets for $Aramark (ARMK.US)$ from 6 analysts:
Note:
TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.
Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.
TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.
美东时间11月13日，多家华尔街大行更新了$Aramark (ARMK.US)$的评级，目标价介于40美元至46美元。
摩根士丹利分析师Toni Kaplan维持持有评级，并将目标价从38美元上调至40美元。
摩根大通分析师Andrew Steinerman维持买入评级，并将目标价从41美元上调至45美元。
瑞士银行分析师Joshua Chan维持买入评级，并将目标价从44美元上调至46美元。
富瑞集团分析师Stephanie Moore维持买入评级，维持目标价45美元。
斯迪富分析师Shlomo Rosenbaum维持买入评级，并将目标价从43美元上调至45美元。
此外，综合报道，$Aramark (ARMK.US)$近期主要分析师观点如下：
该公司根据aramark报告的第四季度有机增长情况，将未来调整后的aoi估计分别上调了1.5%（2025财年）和3%（2026财年），尽管增长幅度温和。公司的aoi和每股收益大致符合预期，且其2025财年的前景也达到了预期。
aramark最近一季度的表现被描述为喜忧参半。公司经历了一些显著的合同终止，并有意退出了利润较低的合同，同时还有一些重要的交易被推迟到下一个季度，导致第四季度的营业收入和前瞻性指引未能达成预期。尽管如此，这些事件被认为是偶发的，并不代表公司整体方向的变化。在分析师眼中，该公司的叙述仍然是积极的。
该公司表示，第四季度的业绩与业务预期一致，并指出有机营业收入增长如预期放缓，同时aoi利润率稳健且符合预测。
以下为今日6位分析师对$Aramark (ARMK.US)$的最新投资评级及目标价：
提示:
TipRanks为独立第三方，提供金融分析师的分析数据，并计算分析师推荐的平均回报率和胜率。提供的信息并非投资建议，仅供参考。本文不对评级数据和报告的完整性与准确性做出认可、声明或保证。
TipRanks提供每位分析师的星级，分析师星级代表分析师所有推荐的过往表现，通过分析师的总胜率和平均回报率综合计算得出，星星越多，则该分析师过往表现越优异，最高为5颗星。
分析师总胜率为近一年分析师的评级成功次数占总评级次数的比率。评级的成功与否，取决于TipRanks的虚拟投资组合是否从该股票中产生正回报。
总平均回报率为基于分析师的初始评级创建虚拟投资组合，并根据评级变化对组合进行调整，在近一年中该投资组合所获得的回报率。
